ASH 2022 Conference Coverage
ASH 2022 Health-Related QOL in Patients With Hemophilia A or B With Inhibitors on Concizumab Prophylaxis: Results From the Phase 3 explorer7 Study
By
ASH 2022 Conference Coverage
FEATURING
Amy Shapiro
By
ASH 2022 Conference Coverage
FEATURING
Amy Shapiro
Login to view comments.
Click here to Login